We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
(+5%)
Cap. Flow
+$425M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Baker Hughes
BKR
|
+$26.7M |
| 3 |
IQVIA
IQV
|
+$14.5M |
| 4 |
Oneok
OKE
|
+$14.3M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$114M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$88.6M |
| 3 |
BHI
Baker Hughes
BHI
|
+$41.6M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$26.7M |
| 5 |
UnitedHealth
UNH
|
+$22.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.64% |
| 2 | Technology | 15.8% |
| 3 | Healthcare | 13.57% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Tejon Ranch
TRC
$457M
| $439K | ﹤0.01% |
21,419
+134
| +0.6% | +$2.69K |
|
|
OME
2377
DELISTED
Omega Protein
OME
| $438K | ﹤0.01% |
26,294
+285
| +1% | +$4.63K |
|
2378
Sterling Infrastructure
STRL
$18.3B
| $435K | ﹤0.01% |
28,585
+225
| +0.8% | +$2.84K |
|
2379
Intellia Therapeutics
NTLA
$1.49B
| $434K | ﹤0.01% |
17,456
+290
| +2% | +$5.46K |
|
2380
V2X
VVX
$2.83B
| $434K | ﹤0.01% |
14,069
+145
| +1% | +$4.49K |
|
|
ELGX
2381
DELISTED
Endologix Inc
ELGX
| $432K | ﹤0.01% |
9,687
+129
| +1% | +$5.88K |
|
|
ORC
2382
Orchid Island Capital
ORC
$1.3B
| $431K | ﹤0.01% |
8,459
+885
| +12% | +$43.5K |
|
2383
ProPetro Holding
PUMP
$1.36B
| $430K | ﹤0.01% |
29,965
+810
| +3% | +$10.2K |
|
|
SHYF
2384
DELISTED
The Shyft Group
SHYF
| $430K | ﹤0.01% |
38,952
+565
| +1% | +$5.26K |
|
|
KEYW
2385
DELISTED
The KEYW Holding Corporation
KEYW
| $430K | ﹤0.01% |
56,470
+345
| +0.6% | +$2.8K |
|
|
MRT
2386
DELISTED
MedEquities Realty Trust, Inc.
MRT
| $429K | ﹤0.01% |
36,474
+1,469
| +4% | +$17.4K |
|
|
MOFG
2387
DELISTED
MidWestOne Financial Group
MOFG
| $428K | ﹤0.01% |
12,672
+150
| +1% | +$5.06K |
|
|
ACBI
2388
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $428K | ﹤0.01% |
23,605
+240
| +1% | +$4.38K |
|
2389
Sonida Senior Living
SNDA
$1.91B
| $427K | ﹤0.01% |
2,268
+69
| +3% | +$13.5K |
|
|
NCOM
2390
DELISTED
National Commerce Corporation
NCOM
| $426K | ﹤0.01% |
9,956
-15
| -0.2% | -$601 |
|
2391
Celldex Therapeutics
CLDX
$2.99B
| $425K | ﹤0.01% |
9,908
+64
| +0.7% | +$2.4K |
|
|
REVG
2392
DELISTED
REV Group
REVG
| $425K | ﹤0.01% |
14,781
+255
| +2% | +$6.7K |
|
|
TVRD
2393
Tvardi Therapeutics
TVRD
$19.7M
| $424K | ﹤0.01% |
861
+13
| +2% | +$6.51K |
|
|
EXAC
2394
DELISTED
Exactech Inc
EXAC
| $421K | ﹤0.01% |
12,777
+50
| +0.4% | +$1.5K |
|
|
CRR
2395
DELISTED
Carbo Ceramics Inc.
CRR
| $420K | ﹤0.01% |
48,617
+3,053
| +7% | +$21.6K |
|
2396
The RMR Group
RMR
$325M
| $419K | ﹤0.01% |
8,151
+70
| +0.9% | +$3.46K |
|
2397
Digimarc Corp
DMRC
$147M
| $418K | ﹤0.01% |
11,425
+160
| +1% | +$5K |
|
|
BAS
2398
DELISTED
Basis Energy Services, Inc.
BAS
| $417K | ﹤0.01% |
21,590
+130
| +0.6% | +$2.58K |
|
2399
First Mid Bancshares
FMBH
$1.39B
| $416K | ﹤0.01% |
10,833
+30
| +0.3% | +$1.06K |
|
2400
Rapid7
RPD
$645M
| $416K | ﹤0.01% |
23,641
+310
| +1% | +$5.15K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2017 Portfolio in Review
As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
- RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
- RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
- RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
- RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
- RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.